Variant NM_000492.4:c.2657+5G>A
Name | NM_000492.4:c.2657+5G>A |
Protein name | NP_000483.3:p.(=) |
Genomic name (hg19) | chr7:g.117242922G>A UCSC |
#Exon/intron | intron 16 |
Legacy Name | 2789+5G>A |
Class | disease-causing |
Subclass | varying clinical consequence |
WT sequence | TGTGCTGTGGCTCCTTGGAAAGTGA G TATTCCATGTCCTATTGTGTAGATT |
Mutant sequence | TGTGCTGTGGCTCCTTGGAAAGTGA A TATTCCATGTCCTATTGTGTAGATT |
dbSNP rs80224560 |
Not found |
Modulator | FDA approval | EMA approval | in vitro / ex vivo data | clinical data |
IVA | yes | no | no | yes |
TEZ-IVA | yes | yes | no | yes |
ELX-TEZ-IVA | no | no | no | no |
clinical and functional data are provided by Vertex
No patient found in CFTR-NGS catalogue |
TOTAL NUMBER OF PATIENTS | 125 |
---|---|
CF | 70 |
CFTR-RD | 35
|
Fetal bowel anomalies | 1 |
Pending | 2 |
Pending (NBS) | 17 |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
Phenotype | Patient ID | Variant status | Additional variants |
---|---|---|---|
CF | 2821 | heterozygote | CF-causing - Trans |
CF | 3104 | heterozygote | CF-causing- Undef |
CF | 3113 | heterozygote | CF-causing - Trans |
CF | 3168 | heterozygote | CF-causing - Trans |
CF | 3231 | heterozygote | CF-causing- Undef |
CF | 3289 | heterozygote | CF-causing - Trans |
CF | 3103 | heterozygote | CF-causing- Undef |
CF | 3099 | heterozygote | CF-causing - Trans |
CF | 3097 | heterozygote | CF-causing- Undef |
CF | 2937 | heterozygote | CF-causing - Trans |
CF | 2938 | heterozygote | CF-causing - Trans |
CF | 2939 | heterozygote | CF-causing - Trans |
CF | 2942 | heterozygote | CF-causing- Undef |
CF | 2962 | heterozygote | CF-causing - Trans |
CF | 2983 | heterozygote | CF-causing - Trans |
CF | 2994 | heterozygote | CF-causing - Trans |
CF | 2995 | heterozygote | CF-causing - Trans |
CF | 3021 | heterozygote | CF-causing - Trans |
CF | 3034 | heterozygote | CF-causing - Trans |
CF | 3092 | heterozygote | CF-causing- Undef |
CF | 3409 | heterozygote | CF-causing - Trans |
CF | 4435 | heterozygote | CF-causing - Trans |
CF | 4463 | heterozygote | CF-causing - Trans |
CF | 4502 | heterozygote | CF-causing - Trans |
CF | 4518 | heterozygote | CF-causing - Trans |
CF | 6205 | heterozygote | CF-causing - Trans |
CF | 6005 | heterozygote | CF-causing - Trans |
CF | 4351 | heterozygote | CF-causing- Undef |
CF | 4169 | heterozygote | CF-causing- Undef |
CF | 5571 | heterozygote | CF-causing - Trans |
CF | 3466 | heterozygote | CF-causing- Undef |
CF | 3467 | heterozygote | CF-causing- Undef |
CF | 3556 | heterozygote | CF-causing- Undef |
CF | 3788 | heterozygote | CF-causing- Undef |
CF | 6020 | heterozygote | CF-causing - Trans |
CF | 2807 | heterozygote | CF-causing - Trans |
CF | 19 | heterozygote | CF-causing - Trans |
CF | 617 | heterozygote | CF-causing- Undef |
CF | 5246 | heterozygote | CF-causing - Trans |
CF | 742 | heterozygote | CF-causing- Undef |
CF | 802 | heterozygote | CF-causing- Undef |
CF | 1019 | heterozygote | CF-causing- Undef |
CF | 41 | heterozygote | CF-causing - Trans |
CF | 4688 | heterozygote | CF-causing - Trans |
CF | 126 | heterozygote | CF-causing - Trans |
CF | 156 | heterozygote | CF-causing- Undef |
CF | 262 | heterozygote | CF-causing - Trans |
CF | 282 | heterozygote | CF-causing- Undef |
CF | 321 | heterozygote | CF-causing- Undef |
CF | 1171 | heterozygote | CF-causing - Trans |
CF | 4858 | heterozygote | CF-causing- Undef |
CF | 2072 | heterozygote | CF-causing- Undef |
CF | 2231 | heterozygote | CF-causing- Undef |
CF | 2374 | heterozygote | CF-causing- Undef |
CF | 2552 | heterozygote | CF-causing- Undef |
CF | 2684 | heterozygote | CF-causing- Undef |
CF | 2691 | heterozygote | CF-causing - Trans |
CF | 2729 | heterozygote | CF-causing- Undef |
CF | 2733 | heterozygote | CF-causing - Trans |
CF | 2044 | heterozygote | CF-causing- Undef |
CF | 2013 | heterozygote | CF-causing- Undef |
CF | 1551 | heterozygote | CF-causing - Trans |
CF | 1764 | heterozygote | CF-causing- Undef |
CF | 1805 | heterozygote | CF-causing- Undef |
CF | 1807 | heterozygote | CF-causing- Undef |
CF | 1812 | heterozygote | CF-causing- Undef |
CF | 1819 | heterozygote | CF-causing- Undef |
CF | 1884 | heterozygote | CF-causing- Undef |
CF | 1970 | heterozygote | CF-causing- Undef |
CF | 901 | homozygote | c.2657+5G>A - p.(=) - Trans |
Other | 4583 | heterozygote | CF-causing- Undef |
Other | 3589 | heterozygote | CF-causing - Trans |
Other | 3660 | heterozygote | CF-causing - Trans |
Other | 801 | heterozygote | CF-causing - Trans |
Other | 853 | heterozygote | CF-causing - Trans |
Other | 4730 | heterozygote | VUS3- Undef |
Other | 2021 | heterozygote | CF-causing- Undef |
Bronchiectasis | 2988 | heterozygote | CFTR-RD-causing - Trans CF-causing - Trans |
Bronchiectasis | 4421 | heterozygote | CF-causing - Trans |
Bronchiectasis | 767 | heterozygote | varying clinical consequence - Trans |
Bronchiectasis | 4734 | heterozygote | CF-causing- Undef |
Bronchiectasis | 1902 | heterozygote | CF-causing- Undef |
CBAVD | 3311 | heterozygote | varying clinical consequence- Undef |
CBAVD | 3376 | heterozygote | CF-causing - Trans |
CBAVD | 4419 | heterozygote | CF-causing- Undef |
CBAVD | 4551 | heterozygote | CF-causing - Trans |
CBAVD | 3414 | heterozygote | varying clinical consequence- Undef |
CBAVD | 892 | heterozygote | CFTR-RD-causing- Undef CFTR-RD-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 613 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 4838 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 519 | heterozygote | CF-causing - Trans |
CBAVD | 1369 | heterozygote | CF-causing- Undef |
CBAVD | 4874 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 4879 | heterozygote | likely CFTR-RD- Undef |
CBAVD | 2649 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 1672 | heterozygote | CF-causing- Undef |
CBAVD | 1878 | heterozygote | CF-causing- Undef |
CBAVD | 2800 | heterozygote | CFTR-RD-causing - Trans varying clinical consequence - Trans |
CRS-NP | 95 | heterozygote | CF-causing- Undef |
CRS-NP | 4513 | heterozygote | CF-causing - Trans |
Pending (NBS) | 5013 | heterozygote | non-CF - Trans |
Pending (NBS) | 4631 | heterozygote | CF-causing- Undef |
Pending (NBS) | 4644 | heterozygote | CF-causing- Undef |
Pending (NBS) | 4751 | heterozygote | CF-causing - Trans |
Pending (NBS) | 2905 | heterozygote | CF-causing - Trans |
Pending (NBS) | 4354 | heterozygote | CF-causing - Trans |
Pending (NBS) | 4137 | heterozygote | CF-causing - Trans |
Pending (NBS) | 3453 | heterozygote | CF-causing- Undef |
Pending (NBS) | 3465 | heterozygote | CF-causing- Undef |
Pending (NBS) | 3817 | heterozygote | CF-causing - Trans |
Pending (NBS) | 3842 | heterozygote | CF-causing- Undef |
Pending (NBS) | 4014 | heterozygote | CF-causing- Undef |
Pending (NBS) | 748 | heterozygote | CF-causing - Trans |
Pending (NBS) | 934 | heterozygote | CF-causing - Trans |
Pending (NBS) | 5536 | heterozygote | CF-causing - Trans |
Pending (NBS) | 5071 | heterozygote | VUS3- Undef VUS3- Undef |
Pending (NBS) | 2727 | heterozygote | CF-causing - Trans |
Fetal bowel anomalies | 584 | heterozygote | CF-causing - Trans |
Pancreatitis | 4614 | heterozygote | varying clinical consequence- Undef |
Pancreatitis | 1044 | heterozygote | |
Pancreatitis | 2147 | heterozygote | VUS3- Undef |
Pancreatitis | 1832 | heterozygote | CF-causing- Undef |
Pending | 3165 | heterozygote | CFTR-RD-causing- Undef |
Pending | 5008 | heterozygote | CF-causing- Undef |
Aquagenic palmoplantar keratoderma | 4660 | heterozygote | CFTR-RD-causing - Trans |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
CFTR variants are clustered into five groups: |
|